- Home
- ULY vs AWH Comparison
ULY vs AWH Comparison
Compare ULY & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULY
- AWH
- Stock Information
- Founded
- ULY 2013
- AWH 1993
- Country
- ULY United States
- AWH United States
- Employees
- ULY N/A
- AWH N/A
- Industry
- ULY
- AWH Medical/Dental Instruments
- Sector
- ULY
- AWH Health Care
- Exchange
- ULY Nasdaq
- AWH Nasdaq
- Market Cap
- ULY 14.8M
- AWH 13.5M
- IPO Year
- ULY N/A
- AWH N/A
- Fundamental
- Price
- ULY $0.63
- AWH $0.76
- Analyst Decision
- ULY Strong Buy
- AWH Buy
- Analyst Count
- ULY 1
- AWH 2
- Target Price
- ULY $2.00
- AWH $4.40
- AVG Volume (30 Days)
- ULY 587.9K
- AWH 61.9K
- Earning Date
- ULY 11-12-2024
- AWH 11-11-2024
- Dividend Yield
- ULY N/A
- AWH N/A
- EPS Growth
- ULY N/A
- AWH N/A
- EPS
- ULY 7.76
- AWH N/A
- Revenue
- ULY $165,727,000.00
- AWH $8,923,000.00
- Revenue This Year
- ULY N/A
- AWH $15.59
- Revenue Next Year
- ULY $20.40
- AWH $108.47
- P/E Ratio
- ULY $0.08
- AWH N/A
- Revenue Growth
- ULY N/A
- AWH N/A
- 52 Week Low
- ULY $0.59
- AWH $0.74
- 52 Week High
- ULY $12.00
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- ULY 31.08
- AWH 36.80
- Support Level
- ULY $0.65
- AWH $0.76
- Resistance Level
- ULY $0.72
- AWH $0.89
- Average True Range (ATR)
- ULY 0.05
- AWH 0.06
- MACD
- ULY -0.00
- AWH 0.01
- Stochastic Oscillator
- ULY 13.33
- AWH 18.40
About ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.